EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSOTSG00005039286
Gene Symbol: DHCR24
1 Cross references
202 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSOTSG00005030473
Gene Symbol: DHCR24
1 Cross references
202 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 12

Ensembl ID : ENSOTSG00005012795
Gene Symbol: LOC112230352
3 Cross references
211 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 14

Ensembl ID : ENSOTSG00005007457
Gene Symbol: LOC112253747
3 Cross references
207 Possible Orthologues:

26s Proteasome Regulatory Subunit 10b-Like

Ensembl ID : ENSOTSG00005029047
Gene Symbol: LOC112245265
3 Cross references
233 Possible Orthologues:

26s Proteasome Regulatory Subunit 10b-Like

Ensembl ID : ENSOTSG00005005907
Gene Symbol: LOC112245265
3 Cross references
233 Possible Orthologues:

26s Proteasome Regulatory Subunit 10b-Like

Ensembl ID : ENSOTSG00005009649
Gene Symbol: LOC112218006
3 Cross references
233 Possible Orthologues:

26s Proteasome Regulatory Subunit 4-Like

Ensembl ID : ENSOTSG00005004029
Gene Symbol: LOC112217937
2 Cross references
32 Possible Orthologues:

26s Proteasome Regulatory Subunit 6a-B-Like

Ensembl ID : ENSOTSG00005042024
Gene Symbol: LOC112232247
3 Cross references
221 Possible Orthologues:

26s Proteasome Regulatory Subunit 6b

Ensembl ID : ENSOTSG00005021175
Gene Symbol: LOC112230372
3 Cross references
190 Possible Orthologues:

26s Proteasome Regulatory Subunit 6b-Like

Ensembl ID : ENSOTSG00005021871
Gene Symbol: LOC112231063
3 Cross references
190 Possible Orthologues:

26s Proteasome Regulatory Subunit 8

Ensembl ID : ENSOTSG00005045358
Gene Symbol: LOC112223827
3 Cross references
222 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).